Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Board revisits Narcan in schools amid safety and staffing concerns
Summary
During a first reading of multiple policy revisions, board members debated whether the district should stock naloxone (Narcan). Proponents cited local overdose data and extended FDA shelf life; the district’s medical advisor raised concerns about necessity given local emergency response times. No formal policy change was recorded.
A lengthy policy discussion at the Onalaska School District board’s March 24 meeting included a contested exchange over whether the district should stock naloxone (commonly known by the brand name Narcan) at school sites.
A board member argued for revisiting the district’s medication policy to permit stocking naloxone in buildings and made a public‑safety case to the board, citing an annual local review: "The 2024 annual report by the La Crosse County Overdose Fatality Review shows that 55 lives were lost in 2023," the…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
